ð« 声ãé²é³ããã ãã§å¿äžå šããããïŒïœNoah Labs VoxãšAIå»çã®æ°æä»£

ã¢ã€
ç®æ¬¡
- 5ç§è©±ãã ãã§å¿èã®ç°åžžããããæä»£ãæ¥ã
- ããèãã3ã€ã®çç±
- ãŸãšãïŒAIå»çã¯ã䟿å©ããããªããŠãåœãæããæè¡
5ç§è©±ãã ãã§å¿èã®ç°åžžããããæä»£ãæ¥ã
ã仿¥ã®äœèª¿ã¯ã©ãã§ããïŒãââãã®è³ªåã«çããã ãã§ãå¿èã®ç°åžžããããããã«ãªã£ããããããªãïŒãããç é¢ã«è¡ããªããŠããèªå® ã§ã¹ããã«5ç§è©±ãã ãã§ã
ãããããSFã®è©±ãããªããã ãããNoah Labsã£ãŠãããã«ã¹ã±ã¢ã¹ã¿ãŒãã¢ãããéçºãããVoxããšããAIããã€ã¹ãããŸãã«ãããå®çŸããããšããŠãã5ç§éã®é³å£°é²é³ããå¿äžå šã®æªåãæ€ç¥ããæè¡ã§ãFDAããããã¬ãŒã¯ã¹ã«ãŒããã€ã¹ãã®èªå®ãåããã® ð
ããããAIé¢é£ã®ãã¥ãŒã¹ã¯æ¯æ¥è¿œããããŠããã©ãä»åã®ãã¥ãŒã¹ã¯æ£çŽã°ããšãããã ã£ãŠãChatGPTãæç« ãæžããšããAIãçµµãæããšããããããã®ã䟿å©ã ãã©ããAIãåœãæããã£ãŠæ¬¡å ãéããããªãïŒ
å¿äžå šã£ãŠãæ¥æ¬ã§ãæ£è æ°ãçŽ120äžäººããŠãé«éœ¢åãšãšãã«ã©ãã©ãå¢ããŠããå¿äžå šãæªåããŠææ¥æ¬éãããã±ãŒã¹ãå€ããŠããããã¡ãã£ãšæ©ãæ°ã¥ããŠããã°âŠããšããããšãå°ãªããªããVoxã¯ãããããããã¡ãã£ãšæ©ãæ°ã¥ãããAIã§å®çŸããããšããŠãããã
ãããããããã¡ã®ç掻ã«ã©ã圱é¿ããã®ããã©ããããä¿¡é Œã§ããæè¡ãªã®ãã仿¥ã¯è©³ããèŠãŠãããã
ããèãã3ã€ã®çç±
声ã«é ããå¿äžå šã®ãµã€ã³ãAIãèŠã€ãåºãä»çµã¿
ã声ã§å¿äžå šããããã£ãŠãã©ãããããšïŒãã£ãŠæåã¯äžæè°ã ãããããããæåã¯ãã³ãšããªãã£ããã§ã説æãèããšããªãã»ã©ãã£ãŠãªãã
å¿äžå šãæªåãããšãèºã«æ°ŽãæºãŸãïŒèºãã£è¡ïŒãã ãããèºã«æ°ŽãæºãŸããšãåŒåžã®ä»æ¹ãå€ããã
åŒåžã®ä»æ¹ãå€ãããšã声ã®åºãæ¹ãå€ãããã€ãŸãã声ã«ã¯å¿äžå šã®æªåã«äŒŽã埮åŠãªå€åãå«ãŸããŠãã®ã
ãã ããã®å€åã¯äººéã®è³ã§ã¯èãåããªãã¬ãã«ã®ãã®ã声ã®ããããæ¯å¹ ãåŒåžãã¿ãŒã³ãå£°åž¯ã®æ¯åã®åŸ®åŠãªå€åââãããã£ããé³é¿ç¹åŸŽããAIãåæããŠãããã
Medical Device Networkã®å ±éã«ãããšãVoxã®AIã¢ã«ãŽãªãºã ã¯300äžä»¶ä»¥äžã®é³å£°ãµã³ãã«ã§èšç·ŽãããŠãã300äžä»¶ã£ãŠçžåœãªéã ãããããã ãã®æ°ã®ããŒã¿ãããã°ããå¿äžå šãæªåããŠããšãã®å£°ã®ãã¿ãŒã³ããšãæ£åžžãªãšãã®å£°ã®ãã¿ãŒã³ãã®éãããããªãæ£ç¢ºã«èŠåããããããã«ãªãã¯ãã
å ·äœçãªäœ¿ãæ¹ãšããŠã¯ãå¿äžå šæ£è ãæ¯æ¥5ç§éãã¹ãããã¿ãã¬ããã«åãã£ãŠè©±ãããã®é²é³ãVoxã®AIãåæããŠãããç°åžžãæ€ç¥ãããå»åž«ã«éç¥ãè¡ããæ£è ã¯èªå® ã«ãããŸãŸã24æéã¢ãã¿ãªã³ã°ãããŠãç¶æ ã«ãªãããã
ããããããã®ã¯ãä»ãŸã§ã®å¿äžå šã®ã¢ãã¿ãªã³ã°ã£ãŠã宿çã«ç é¢ã«éã£ãŠæ€æ»ãåããããäœéèšã«ä¹ã£ãŠäœéã®æ¥å¢ïŒäœæ¶²è²¯çã®ãµã€ã³ïŒããã§ãã¯ããããããããªãã£ãã®ãäœéèšã¯æ¯æ¥ä¹ããªã人ãå€ãããç é¢ã¯æ°é±éã«1åããã®éã«æ¥æ¿ã«æªåããããšãããã
Voxãªãæ¯æ¥5ç§ã®é²é³ã§æžããããæ£è ã®è² æ ãã»ãšãã©ãªãããããAIããªã¢ã«ã¿ã€ã ã§åæããŠããããããæªåã®åæå åãèŠéããªããç é¢ã«è¡ãã¹ãã¿ã€ãã³ã°ãé©åã«æããŠãããããã ããã
ãããã®åšãã«ãå¿èã«æç ãæã£ãŠãå®¶æããã人ããããããããããæè¡ãæ©ãå®çšåãããŠã»ããã£ãŠå¿ããæããæ¯æ¥5ç§è©±ãã ãã§å®å¿ãåŸããããªãããããªãçç±ããªãããã
æè¡çã«ããå°ãæãäžãããšãVoxãæ€åºããŠãã®ã¯äž»ã«ãèºãã£è¡ãã®å åãå¿äžå šãæªåãããšå¿èã®ãã³ãæ©èœãäœäžããŠãèºã«è¡æ¶²ãæºãŸãã
ãã®çµæãèºã®äžã®ç©ºæ°ã®éãéãçããªã£ãŠãåŒåžã®ãã¿ãŒã³ãå€ããããã®åŸ®åŠãªåŒåžãã¿ãŒã³ã®å€åãã声ã®é³é¿ç¹åŸŽã«åæ ããããã ããã
人éã®å»åž«ããã®å€åãèŽèšºåšã§èŽãåãã«ã¯ãããªãã®çµéšãå¿ èŠããããèŽèšºåšã䜿ããã®ã¯æ£è ãç é¢ã«æ¥ããšãã ãã
Voxãªãèªå® ã«ããªããæ¯æ¥ã¢ãã¿ãªã³ã°ã§ããããããæ¬¡ã®å€æ¥å蚺ãŸã§ããš2é±éãã£ãŠããéã«èµ·ããæ¥å€ãèŠéããªããããã¯æ¬åœã«ç»æçãªããšã ãšæãã
FDAãã¬ãŒã¯ã¹ã«ãŒèªå®ã¯ãæ¬ç©ãã®èšŒæ
ããã§ã¡ãã£ãšéèŠãªãã€ã³ãããFDAãã¬ãŒã¯ã¹ã«ãŒããã€ã¹èªå®ãã£ãŠã©ããããã®ãªã®ã説æããŠãããããããããã倧äºã ããã
FDAïŒç±³åœé£åå»è¬åå±ïŒã®ãã¬ãŒã¯ã¹ã«ãŒããã€ã¹èªå®ã¯ã2016幎ã«å§ãŸã£ãããã°ã©ã ã§ããæ¢åã®æ²»çæ³ãèšºææ³ãããå€§å¹ ã«åªããŠããå¯èœæ§ãããå»çæ©åšãã«å¯ŸããŠäžãããããèªå®ãåãããšã審æ»ããã»ã¹ãåªå çã«é²ããããŠãåžå Žæå ¥ãŸã§ã®æéãççž®ãããã
ãã€ã³ãã¯ããã¬ãŒã¯ã¹ã«ãŒèªå®ã¯ãæ¿èªãã§ã¯ãªããã©ãFDAãããã®æè¡ã«ã¯æ¬åœã®å¯èœæ§ãããããšèªããã£ãŠããšãç³è«ããã°èª°ã§ãããããã®ãããªããŠãå³ãã審æ»ãçµãŠèªå®ããããAIå»çããã€ã¹ã§ãã¬ãŒã¯ã¹ã«ãŒèªå®ãåãããã®ã¯ãŸã ãããŸã§å€ããªããããVoxã®æè¡çä¿¡é Œæ§ã¯ããªãé«ããšèŠãŠãããšæãã
Noah Labsã®ãã¬ã¹ãªãªãŒã¹ã«ãããšãVoxã¯ã¡ã€ãšãŒã¯ãªããã¯ïŒäžçæé«å³°ã®å»çæ©é¢ã®äžã€ïŒãã«ãªãã©ã«ãã¢å€§åŠãµã³ãã©ã³ã·ã¹ã³æ ¡ïŒUCSFïŒãšã®5ã€ã®å€æœèšèšåºè©Šéšã§æ€èšŒæžã¿ãã¡ã€ãšãŒã¯ãªããã¯ãåå ããŠãã£ãŠã ãã§ä¿¡é ŒåºŠãè·³ãäžããããã
ãããäžã§ã¯ãAIã®å»çå¿çšã¯æããã誀蚺ãããã©ãããã®ïŒãã£ãŠãã声ãããããã®äžå®ã¯ããããã§ãVoxã®å ŽåãAIãæçµçãªèšºæãäžããããããªãã
AIãç°åžžãæ€ç¥ããŠå»åž«ã«éç¥ããå»åž«ã倿ãããã€ãŸããAIã¯ãã¹ã¯ãªãŒãã³ã°ïŒãµããåãïŒãã®åœ¹å²ã§ãæçµå€æã¯äººéãããèšèšã«ãªã£ãŠãã
ããã¯AIå»çã®æ£ããã¢ãããŒãã ãšæããAIãããã®æ£è ã¯å¿äžå šãæªåããŠãŸããã£ãŠæå®ããããããªããŠãããã®æ£è ã®å£°ã«ç°åžžãèŠãããŸãã
確èªããŠãã ãããã£ãŠå»åž«ã«ã¢ã©ãŒããåºããAIãšäººéãååãã圢ã«ãªã£ãŠãããã誀蚺ã®ãªã¹ã¯ãæå°éã«æããããã
ãããçã«ã¯ããããããAIãå»åž«ãå©ãããã¿ã€ãã®æè¡ã¯ã©ãã©ãé²ããã¹ãã ãšæããå»åž«ã®æ°ãè¶³ããªãåé¡ã¯äžçäžã§ããããæ¥æ¬ãäŸå€ãããªããAIãã«ãŒãã£ã³ã®ã¢ãã¿ãªã³ã°ãæ åœããŠãããã°ãå»åž«ã¯ãã£ãšè€éãªçäŸã«éäžã§ããã
å¿äžå šã«éãããä»åŸã¯å£°ãé¡è²ãæ©ãæ¹ãã¿ã€ãã³ã°ãã¿ãŒã³ãªã©ãæ¥åžžçãªããŒã¿ããAIãå¥åº·ç¶æ ãæšå®ããæè¡ãã©ãã©ãåºãŠãããšæããããªããšãªãäœèª¿æªãããããŒã¿ã§è£ä»ããŠãããAIãããã°ãç é¢ã«è¡ããã£ãããå¢ããŠãæ©æçºèŠã»æ©ææ²»çã«ã€ãªããããã
ããã§èããŠããããã®ãå»çè²»åæžã®èгç¹ãå¿äžå šã®æ¥æ§å¢æªã§ææ¥æ¬éã»å ¥é¢ãããšã1åãããæ°åäžåãã100äžå以äžã®å»çè²»ããããã
ããVoxã§æ©æã«ç°åžžãæ€ç¥ããŠã倿¥ã¬ãã«ã§ã®å¯Ÿå¿ã§æžãŸããããããå»çè²»ã¯å€§å¹ ã«äžãããå»çè²»ãå¢ãç¶ããŠãå é²åœã«ãšã£ãŠãäºé²å»çã®ã³ã¹ãåæžå¹æã¯èšãç¥ããªãã
ä¿éºäŒç€Ÿããã®æè¡ã«æ³šç®ããŠãã¯ãããVoxã䜿ã£ãŠãæ£è ã¯å ¥é¢ãªã¹ã¯ãäœããã£ãŠããããŒã¿ãèç©ãããã°ãä¿éºæã®å²åŒã«ã€ãªãããããããªããå¥åº·ä¿éºã®ä»çµã¿èªäœããAIã¢ãã¿ãªã³ã°ã®æ®åã«ãã£ãŠå€ãã£ãŠããå¯èœæ§ããããã ããã
ã¹ãããèŽèšºåšã«ãªãæªæ¥ã¯ãããã
Voxã®è©±ãèããŠãããããçã£å ã«æã£ãã®ã¯ããããå°æ¥çã«ã¯ã¹ããã®æšæºæ©èœã«ãªãããããªãïŒãã£ãŠããšã
èããŠã¿ãŠãApple Watchã¯å¿ææ°ã¢ãã¿ãªã³ã°ãå¿é»å³æ©èœããã§ã«æèŒããŠãã
iPhoneã«ã¯ãã«ã¹ã±ã¢ã¢ããªããã£ãŠãæ©æ°ãç¡ç ããŒã¿ãèšé²ããŠããããã«ã声ããå¥åº·ç¶æ ãæšå®ããæ©èœãã远å ããããïŒæ¯æSiriã«ããã¯ãããã£ãŠèšãã ãã§ãå¿èã®ç¶æ ããã§ãã¯ãããäžçãæ¥ããããããªãã
Cardiovascular Businessã®å ±éã§ããFDAãé³å£°ããŒã¹ã®AIå»çã¢ãã«ã«ãå¯èœæ§ãèŠãŠããããšè©äŸ¡ããŠããã€ãŸããèŠå¶åœå±ããã®æ¹åæ§ãæ¯æããŠãã£ãŠããšã
äžéã§ã¯ãAIå»çã¯çµå±ãå é²åœã®éæã¡ãã䜿ããªããã§ãããã£ãŠãã声ãããã確ãã«ãææ°ã®å»çæ©åšã¯é«äŸ¡ãªããšãå€ããã§ãVoxã®å Žåãå¿ èŠãªã®ã¯ã¹ããïŒãŸãã¯ã¿ãã¬ããïŒãšã€ã³ã¿ãŒãããæ¥ç¶ã ãã
ç¹å¥ãªããŒããŠã§ã¢ã¯äžèŠãããã¯éäžåœãå«ãäžçäžã®æ£è ã«ãšã£ãŠé©åœçãªããšã ããã
å¿äžå šæ£è ã®ã¢ãã¿ãªã³ã°ã ããããªããŠããã®æè¡ãå¿çšãããå¯èœæ§ã¯ãã¡ããã¡ãåºãããã€ç ãããŒãã³ãœã³ç ãèºçŸæ£ââ声ã«å€åãçŸããç æ°ã¯ãããããããVoxã®æåã蚌æãããã°ãåãã¢ãããŒãã§å¥ã®ç æ°ãæ€ç¥ããAIãæ¬¡ã ãšç»å Žããã¯ãã
ãã ãããã©ã€ãã·ãŒã®åé¡ã¯èããŠããå¿ èŠããããæ¯æ¥ã®é³å£°ããŒã¿ãå»çæ©é¢ã«éãããããã ããããã®ããŒã¿ãã©ã管çããããã¯éèŠãå¥åº·ããŒã¿ã¯æãã»ã³ã·ãã£ããªå人æ å ±ã®äžã€ã ãããæå·åãã¢ã¯ã»ã¹å¶åŸ¡ããã£ããããŠãªããšå°ãã
Noah Labsã¯2026幎åã°ãŸã§ã«EUæ¿èªããã®åŸFDAæ¿èªãç®æããŠãããããæ¥æ¬ã§ã¯ãŸã å ã®è©±ã«ãªããããããªããã©ãEUã»ç±³åœã§æ¿èªãããã°ãæ¥æ¬ã§ã®å±éãé ããªãã¯ãã
æ¥æ¬ã®é«éœ¢å瀟äŒãèãããšãããããæè¡ã®éèŠã¯ç¹ã«å€§ãããæ¥æ¬ã®å¿äžå šæ£è æ°ã¯å¹Žã å¢å ããŠãŠã2030幎ã«ã¯130äžäººãè¶ ãããšäºæž¬ãããŠãã
å°æ¹ã§ã¯åŸªç°åšå°éå»ãäžè¶³ããŠãå°åãå€ããAIé éã¢ãã¿ãªã³ã°ãæ®åããã°ãå°æ¹ã®æ£è ã§ãéœåžéšãšåçã®ã±ã¢ãåããããããã«ãªãã
ãã ãæ¥æ¬ã§å»çAIããã€ã¹ãå±éããã«ã¯è¬äºæ¿èªã®ããŒãã«ããããPMDAã®å¯©æ»ã¯FDAãšæ¯ã¹ãŠæéããããåŸåããããããæ¥æ¬ã§äœ¿ããããã«ãªãã®ã¯2027幎以éãããããªããã§ããFDAãã¬ãŒã¯ã¹ã«ãŒèªå®ãåã£ãŠã補åã¯PMDAãæ³šç®ããã¯ãã ãããåŸæ¥ããã¯æ©ã審æ»ãé²ãå¯èœæ§ã¯ããããã
å»ççŸå Žã®å£°ãšããŠããAIã«é ŒããããŠå»åž«ã®å€æåãäœäžããããããªãããã£ãŠããæžå¿µããããVoxããç°åžžãªããã£ãŠèšã£ããå®å¿ãã¡ãã£ãŠãå®ã¯å¥ã®åå ã§äœèª¿ãæªåããŠãã®ãèŠéãââã¿ãããªã·ããªãªãã ãããããVoxã¯ãå»åž«ã®ä»£ããããããªããŠãå»åž«ã®è£å©ãã§ããã£ãŠããäœçœ®ã¥ãã倧äºãªãã ããã
ã¡ãªã¿ã«ãVoxã®ãããªAIå»çããã€ã¹ã®ããžãã¹ã¢ãã«ãæ°ã«ãªããšãããããããSaaSåã®ãµãã¹ã¯ãªãã·ã§ã³ã¢ãã«ã«ãªããšæããã©ãä¿éºé©çšããããã©ããã§æ®åé床ãå šç¶å€ããã
ã¢ã¡ãªã«ã§ã¯CMSïŒCenters for Medicare and Medicaid ServicesïŒããªã¢ãŒãã¢ãã¿ãªã³ã°ã«ä¿éºé©çšãèªããŠããããVoxããã®æ çµã¿ã«å ¥ããå¯èœæ§ããããä¿éºãå¹ãã°æ£è è² æ ãæžã£ãŠãäžæ°ã«æ®åããã¯ãã
ããããã¡ãã§ããããšãšããŠã¯ãããããAIå»çæè¡ã®ååã«é¢å¿ãæã€ããšããããŠãèªåãå®¶æã«å¿èã®æç ãããå Žåã¯ããããã£ããªã¢ãŒãã¢ãã¿ãªã³ã°ãµãŒãã¹ã䜿ããããã«ãªã£ããç©æ¥µçã«æ€èšããŠã¿ãããšãããã£ã5ç§ã®é²é³ãã§å®å¿ãåŸããããªãã䜿ããªãæã¯ãªããã ð¥
ãŸãšãïŒAIå»çã¯ã䟿å©ããããªããŠãåœãæããæè¡
Noah Labs Voxã瀺ããã®ã¯ãAIãå»çã®äžçã§æ¬åœã«åœ¹ã«ç«ã€ã£ãŠããšãChatGPTãæç« ãæžãã®ãšã¯æ¬¡å ãéã話ã§ã5ç§ã®å£°ããå¿äžå šã®æªåãæ€ç¥ã§ãããªããå®éã«äººã®åœãæããã
FDAã®ãã¬ãŒã¯ã¹ã«ãŒèªå®ãã¡ã€ãšãŒã¯ãªããã¯ã§ã®èšåºè©Šéšã300äžä»¶ã®é³å£°ãµã³ãã«ã«ãããã¬ãŒãã³ã°ââããã ãã®ãšããã³ã¹ãæã£ãŠããããããŸãAIã®å€§ãããªå®£äŒã§ããããšã¯èšããªãã¬ãã«ã
AIå»çã¯ä»åŸãã©ãã©ãé²åããŠãããšæããã¹ãããèŽèšºåšã«ãªãæä»£ã¯ããããã ãã
Voxã®æåããã£ããã§ã声以å€ã®ãã€ãªããŒã«ãŒââ衚æ ãå§¿å¢ãæ©è¡ãã¿ãŒã³ãã¿ã€ãã³ã°é床ââãããå¥åº·ç¶æ ãæšå®ããAIãã©ãã©ãåºãŠããã¯ãã5幎åŸã«ã¯ãã¹ããããŠã§ã¢ã©ãã«ããã€ã¹ãåžžæå¥åº·ãã¢ãã¿ãªã³ã°ããŠããã¡ãã£ãšäœèª¿ã«å€åããããŸãããã£ãŠæããŠãããæä»£ãæ¥ããããããªãã
ããããã¡ã«ã§ããããšã¯ããããã£ãæè¡ã®é²æ©ãç¥ã£ãŠã䜿ãããã®ã¯ç©æ¥µçã«äœ¿ãããšããããŠèªåãå®¶æã®å¥åº·ããŒã¿ã«é¢å¿ãæã€ããšããAIã«å šéšä»»ãããããããªããŠãAIã®åãåããŠèªåã®å¥åº·ãèªåã§ç®¡çããââããããæä»£ãæ¥ãŠããã ãšæãã
æåŸã«ã²ãšã€ãNoah Labsã®Voxãæåããã°ã次ã¯ä»ã®æ ¢æ§çŸæ£ââç³å°¿ç ãCOPDïŒæ ¢æ§é塿§èºçŸæ£ïŒããã€ç ãªã©ââãžã®å¿çšãé²ãã¯ãã
声ã ããããªããŠãæ¥åžžã®è¡åãã¿ãŒã³å šäœããå¥åº·ãæšå®ãããã¢ã³ããšã³ãã»ãã«ã¹ã¢ãã¿ãªã³ã°ãããæ¬¡ã®ããã³ãã£ã¢ã«ãªããšæãããŠã§ã¢ã©ãã«ããã€ã¹ã®é²åãšçµã¿åãããã°ãããããã¡ã®å¥åº·ç®¡çã¯ä»ãšå šãéã圢ã«ãªãããã
ãããŠãã®æè¡ã¯ãå»çè²»ã®åé¡ãæ±ããŠãå šãŠã®åœã«ãšã£ãŠåžæã«ãªããããäºé²å»çã«AIãæŽ»çšããŠãéçåããåã«ä»å ¥ããã
ãããåœããåã«ãªãã°ãå»çå¶åºŠã®æç¶å¯èœæ§ãé«ãŸããNoah Labs Voxã¯å°ããªã¹ã¿ãŒãã¢ããã®äžã€ã®è£œåã ãã©ããã®å ã«èŠããæªæ¥ã¯ãšãŠã倧ãããã ããã
å°æ¥çã«ã¯ãæ¯æã¹ããã«ããã¯ãããã£ãŠè©±ããããã ãã§ãå¿èã ããããªããŠå šèº«ã®å¥åº·ç¶æ ããã§ãã¯ããŠãããAIãæšæºè£ åãããæ¥ãæ¥ããããããªããããã¯ãSFæ ç»ã®äžçããããªããŠãVoxã®ãããªæè¡ã®å»¶é·ç·äžã«ãããæã®å±ãæªæ¥ãªãã ããã
Apple WatchãGalaxy Watchã®ãããªæ¢åã®ãŠã§ã¢ã©ãã«ããã€ã¹ãšã®é£æºãæåŸ ããããšãããå¿æããŒã¿ãšVoxã®é³å£°åæãçµã¿åãããã°ãããã«ç²ŸåºŠã®é«ãå¥åº·ã¢ãã¿ãªã³ã°ãå®çŸã§ããã¯ãã
ãã«ã¹ã±ã¢ããã¯ã®åãã¬ã€ã€ãŒã飿ºããŠããããšã§ãããããã¡ã®å¥åº·ç®¡çã®è³ªã¯é£èºçã«åäžããããã®ç¬¬äžæ©ãšããŠãVoxã®åçšåãæåããããšãå¿ããé¡ã£ãŠãã
仿¥ã®ãã¥ãŒã¹ã¯ãAIã£ãŠäŸ¿å©ã ãããè¶ ããŠãAIã£ãŠåœãæãããã ãã£ãŠããããšãŠã倧äºãªè©±ã ã£ããšæã âš
é¢é£èšäº: AIå¹çåããŒã«åŸ¹åºã¬ãã¥ãŒ
ãœãŒã¹:
- Noah Labs lands FDA breakthrough designation for AI voice-based heart failure monitor | Medical Device Network
- FDA sees promise in voice-based AI model for heart failure | Cardiovascular Business
- Noah Labs Obtains FDA Breakthrough Device Designation
ãããã質å
- ãã®èšäºã¯ã©ããªå 容ã§ããïŒ
- Noah Labsã®AIããã€ã¹VoxãFDAãã¬ãŒã¯ã¹ã«ãŒèªå®ãååŸã5ç§ã®å£°ããå¿äžå šãæ€ç¥ããæè¡ã®ä»çµã¿ãšãAIå»çãããããã¡ã«ããããå€åã解説ã
- æ å ±ã¯ãã€æç¹ã®ãã®ã§ããïŒ
- 2026-04-06 æç¹ã§ãŸãšããæ å ±ã§ãïŒ2026-04 ã®ååïŒãAIé¢é£ã®åãã¯éããææ°ç¶æ³ã¯å€åããå¯èœæ§ããããããå ¬åŒçºè¡šãäžæ¬¡ãœãŒã¹ãããããŠç¢ºèªããŠãã ããã
- èªè ãšããŠã©ãåãæ¢ããã°ããã§ããïŒ
- æ¬èšäºã¯ãäžéã®èŠæ¹ããçè ã®èŠè§£ããããŒã¿ã»äºå®ããããããèããŠããããã¢ã¯ã·ã§ã³ãã®æµãã§æŽçããŠããŸããAIããŒã«ã®äœ¿ãæ¹ãä»äºã®ããæ¹ã«é¢ããåããšããŠãèªåã®ç¶æ³ã«çœ®ãæããŠèªãã§ã¿ãŠãã ããã